CAR-T Cell Therapy

Explore clinical trials studying CAR-T Cell Therapy. Study availability and eligibility vary by location and protocol.

17 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

CAR-T Cell Therapy trial results

Not Yet Recruiting

INfections in Patients Treated With CAR-T

NCT07713511

Conditions: B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bloodstream Infections, +29 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Not Yet Recruiting

Pre-emptive Anakinra for Cytokine Event Reduction

NCT06703216

Conditions: B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR-T Cell Therapy, +24 more
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details

Not Yet Recruiting

RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients

NCT07296120

Conditions: Bone Marrow Transplant - Autologous or Allogeneic, CAR-T Cell Therapy, RSV Immunization
Locations: Cooper University Hospital Camden, New Jersey, United States

View Trial Details

Not Yet Recruiting

Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma

NCT06935136

Conditions: CAR-T Cell Therapy, High-risk Large B-cell Lymphoma (LBCL)
Locations: China Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors

NCT06647329

Conditions: CAR-T Cell Therapy, Disease Attributes, Hemic and Lymphatic Diseases, +11 more
Locations: the First Hospital of Zhengzhou University Zhengzhou, Henan, China

View Trial Details

Active, Not Recruiting

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus

NCT06222853

Conditions: Autoimmune Diseases, CAR-T Cell Therapy, Connective Tissue Diseases, +4 more
Locations: Children's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Active, Not Recruiting

A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19

NCT07269587

Conditions: ALL (Acute B-Lymphoblastic Leukemia), CAR-T Cell Therapy
Locations: Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

CAR-T Cell Therapy

CAR-T Cell Therapy trial results

INfections in Patients Treated With CAR-T

Pre-emptive Anakinra for Cytokine Event Reduction

RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients

Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma

CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus

A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19

Related conditions